Pilates vs. Core Stabilization for Balance and Mobility in Elderly Type 2 Diabetics (PCE-DM2)

November 3, 2026 updated by: Aya Ali Elbakly Amer, Beni-Suef University

Impact of Pilates Versus Core Stabilization Exercises on Balance Deficits and Functional Mobility in Elderly Patients With Type 2 Diabetes

This randomized controlled trial aims to evaluate and compare the effects of a 6-week Pilates-based rehabilitation program versus core stabilization exercises on balance deficits, postural sway, and functional mobility in elderly patients with type 2 diabetes. The study seeks to determine which intervention is more effective in improving neuromuscular control, stability, and overall functional independence in this geriatric diabetic population.

Study Overview

Detailed Description

Type 2 diabetes mellitus in elderly individuals is frequently associated with peripheral neuropathy, reduced muscle strength, and balance impairment, leading to an increased risk of falls. Both Pilates and core stabilization exercises are non-pharmacological interventions used to enhance core stability, proprioception, and functional performance.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:Old age patients of both genders (age 65 tob75) diagnosed with Type 2 Diabetes Mellitus.Ability to walk independently with or without assistive devices.

  • Presence of mild to moderate balance deficits confirmed by clinical assessment.

Exclusion Criteria:Any history of severe neurological disorders (e.g., stroke, Parkinson's disease).

  • Uncontrolled cardiovascular conditions or severe orthopedic injuries affecting lower limbs.Visual or vestibular impairments that significantly affect balance.

Cognitive impairment or inability to follow instructions (Mini-Mental State Examination score below normal thresholds

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A -Pilates Training Exercise

Participants in this group will undergo a structured Pilates exercise program

supervised Pilates session lasting for 45 minutes, performed 3 times per week for 8 weeks. It includes mat Pilates exercises focusing on alignment, breathing, and core control)

Active Comparator: Group B:Core Stabilization Group

Participants in this group will undergo a structured core stability training program

supervised Pilates session lasting for 45 minutes, performed 3 times per week for 8 weeks. It includes mat Pilates exercises focusing on alignment, breathing, and core control)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural Balance ABalance and Gait Speedssessment (Berg Balance Scale _Minimum Value): 0 (Maximum Value): 56 (Unit/Direction
Time Frame: Baseline (Week 0) and Post-Intervention (Week 6)

The Berg Balance Scale (BBS) will be used to assess dynamic and static balance deficits in elderly participants.

Baseline (Week 0) and Post-Intervention (Week 6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Mobility (Timed Up and Go Test)
Time Frame: Baseline (Week 0) and Post-Intervention (Week 6)

Functional Mobility (Timed Up and Go Test)

Baseline (Week 0) and Post-Intervention (Week 6)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 29, 2026

Primary Completion (Estimated)

May 27, 2027

Study Completion (Estimated)

July 27, 2027

Study Registration Dates

First Submitted

October 26, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 5, 2026

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared to maintain patient privacy and confidentiality as per institutional guidelines.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe